Estimating the Size and Sheets When Using Integra® Bilayer Wound Matrix

Integra® Bilayer Wound Matrix (IBWM) is an advanced wound care device comprised of a porous matrix of cross-linked bovine tendon collagen and glycosaminoglycan and a semi-permeable polysiloxane (silicone layer).

The semi-permeable silicone membrane controls water vapor loss, provides a flexible adherent covering for the wound surface and adds increased tear strength to the device. The collagen-glycosaminoglycan biodegradable matrix provides a scaffold for cellular invasion and capillary growth.

To ensure best possible outcomes when using Integra® Bilayer Wound Matrix, the product must provide adequate coverage so that it conforms to and is in contact with the prepared wound bed. Integra® Bilayer Wound Matrix must also lay flat with no wrinkles, bubbles or gaps.

The below one-page guide includes:

• • Helpful formulas to calculate the number and size of sheets of IBWM
  • The approximate surface area covered per sheet
  • Estimated number of sheets needed per adult anatomy

Indications

Integra Bilayer Wound Matrix is indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, and skin tears) and draining wounds. The device is intended for one-time use.

Contraindications

• This device should not be used in patients with known sensitivity to bovine collagen or chondroitin materials.
• The device is not indicated for use in third-degree burns.

Precautions

• Do not resterilize. Discard all opened and unused portions of Integra Bilayer Wound Matrix.
• Device is sterile if the package is unopened and undamaged. Do not use if the package seal is broken.
• Discard device if mishandling has caused possible damage or contamination.
• Integra Bilayer Wound Matrix should not be applied until excessive exudate, bleeding, acute swelling and infection are controlled.
• Debridement or excision must be done thoroughly to remove any remaining necrotic tissue that may cause infection.
• The following complications are possible with the use of wound dressings. If any of the conditions occur, the device should be removed: infection, chronic inflammation (initial application of wound dressings may be associated with transient, mild, localized inflammation), allergic reaction, excessive redness, pain or swelling.

Have you heard about our new guarantee program for soft tissue reconstruction? Learn more here.